# OnCo record trabectedin (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/trabectedin/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "trabectedin" ;
  schema:name "Trabectedin"@en ;
  schema:description "A chemotherapy derived from a sea squirt, used with liposomal doxorubicin in relapsed ovarian cancer in Europe and for sarcomas."@en ;
  schema:url <https://onco.cc/drugs/trabectedin/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Trabectedin> ;
  owl:sameAs <http://www.wikidata.org/entity/Q2637746> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Trabectedin> ;
  onco:status "approved" ;
  onco:modality "Cytotoxic (DNA minor-groove binder)" ;
  schema:alternateName "Yondelis" ;
  onco:approval "EU 2009: Relapsed platinum-sensitive ovarian cancer with PLD", "US 2015: Liposarcoma and leiomyosarcoma after anthracycline", "EU 2007: Advanced soft-tissue sarcoma after anthracycline/ifosfamide" ;
  onco:cancers <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/sarcoma/>, <https://onco.cc/cancers/leiomyosarcoma/>, <https://onco.cc/cancers/liposarcoma/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:companies <https://onco.cc/companies/johnson-johnson/> ;
  onco:terms <https://onco.cc/terms/sarcoma-histotype-tailoring/> .